Skip to content
The ESG Weekly: Should investors care about antibiotic resistance? And only a handful of companies are preventing a deforestation‐free supply chain for the week of November 18. episode artwork

EPISODE · Nov 22, 2019 · 14 MIN

The ESG Weekly: Should investors care about antibiotic resistance? And only a handful of companies are preventing a deforestation‐free supply chain for the week of November 18.

from Sustainability Now · host MSCI ESG Research LLC

Two stories this week with ESG glasses: Antibiotic resistance ‐ the ability of germs to defeat the drugs designed to kill them ‐ is one of the greatest public health challenges of our time; but as the crisis grows what will happen to the companies that produce antibiotics (0:54)? And then Mario Lopez‐Alcala tells us which companies are slowing the transition to a deforestation free supply chain in South America (10:17), all through an ESG lens.

Episode metadata supplied by the publisher feed · Published Nov 22, 2019

Embed this episode

Ready to play

The ESG Weekly: Should investors care about antibiotic resistance? And only a handful of companies are preventing a deforestation‐free supply chain for the week of November 18.

0:00 14:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Sustainability Now?

This episode is 14 minutes long.

When was this Sustainability Now episode published?

This episode was published on November 22, 2019.

Can I download this Sustainability Now episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!